Research Directors on the Campuses
DR. PABLO MENÉNDEZ
Campus Clínic-UB Research Director
He graduated in biochemistry and as Doctor of Medicine at the University of Salamanca. His scientific interests lie in the field of hematology/oncology and the transplant of cells and hematopoietic progenitors. He is a specialist in the etiology and pathogenesis of pediatric leukaemia.
In September 2013 he was appointed research director of the Clínic-UB Campus of the Josep Carreras Institute. He was previously trained with Prof. Mick Bhatia at the McMaster Cancer and Stem Cell Biology Research Institute in Toronto and at the Institute of Cancer Research in London together with Prof. Mel Greaves; and he was the director of the Andalusia Stem-cell Bank in Granada and chief researcher at GENyO (Pfizer—University of Granada—Junta of Andalusia Genome and Cancer Research Centre).
Dr. Pablo Menéndez was awarded the triennial ED Thomas Post-Doctoral Fellowship Grant by the Josep Carreras Foundation in 2006 and is currently professor at the Catalan Institution for Research and Advanced Studies, Generalitat de Catalunya. In 2015 his work was recognized with a grant from the European Research Council (ERC).
He has participated in more than 130 articles and has accumulated an impact factor of 1,040 and a factor H-index of 41.
DR. FRANCESC SOLÉ
Campus ICO-Germans Trias i Pujol Research Director
An eminent biologist specialised in the genetic diagnosis of hematological neoplasms. He joined the Josep Carreras Leukemia Research Institute on 1 October 2012 to direct research at the IJC Catalan Institute for Oncology/Germans Trias i Pujol Campus, the line of research being focused on the study of myelodysplastic syndromes (MDS) and the centre’s cytogenetic and microarray platform.
Previously he was the head of the Cytogenetic and Molecular Biology Laboratory of the Hospital del Mar Pathology Service in Barcelona, amongst other posts. At the present time he is president of the Spanish myelodysplastic syndromes group and member of the Experts Committee of the Internationa Working Group for the Prognosis of MDS.
Over recent years he has been working on, and optimising, cytogenetic techniques and he was in charge of standardising in situ hybridisation techniques (FISH), molecular biology and sequencing as applied, mainly, to the diagnosis of hematological
He has published more than 280 articles, with an H-index of 34, and has accumulated an impact factor of 862. His work has been cited in 3,655 articles.
Campus Sant Pau reserahc Director